1.
Elsevier ClinicalKey Drug Monograph
Content last updated: May 3, 2024.
Contraindications And Precautions
Early and aggressive intervention to treat the hyperkalemia and resistant arrhythmias is recommended as is subsequent evaluation for latent neuromuscular disease. Avoid induction and maintenance of anesthesia using sole agents that decrease systemic vascular resistance or diastolic blood pressure, such as sevoflurane, in pediatric patients with acid alpha-glucosidase deficiency (Pompe disease). Life-threatening arrhythmias, including severe bradycardia, torsade de pointes, and fatal ventricular fibrillation have been reported in pediatric patients with infantile-onset Pompe disease. Severe bradycardia and cardiac arrest, unrelated to underlying congenital heart disease, have been reported in pediatric persons with Down syndrome during anesthesia induction with sevoflurane. Closely monitor heart rate and consider incremental increases in inspired sevoflurane concentration during anesthesia induction in this patient population; consider having epinephrine and an anticholinergic medication available for use. Bradycardia improved with decreasing sevoflurane concentration, airway manipulation, or administration of an anticholinergic or epinephrine in most reported cases.
Contraindications And Precautions
Repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in neonates, infants, and children younger than 3 years, including in utero exposure during the third trimester, may have negative effects on brain development. Consider the benefits of appropriate anesthesia in young children against the potential risks, especially for procedures that may last more than 3 hours or if multiple procedures are required during the first 3 years of life. It may be appropriate to delay certain procedures if doing so will not jeopardize the health of the child. No specific anesthetic or sedation drug has been shown to be safer than another. Human studies suggest that a single short exposure to a general anesthetic in young pediatric patients is unlikely to have negative effects on behavior and learning; however, further research is needed to fully characterize how anesthetic exposure affects brain development. Sevoflurane's minimal alveolar concentration (MAC) is higher in children than adults; it is highest in very young children and decreases with increasing age. The MAC in premature neonates has not been established. The use of sevoflurane has been associated with seizures. The majority of these have occurred in infants older than 2 months, children, and young adults, most of whom had no predisposing risk factors. Clinical judgment should be exercised when using sevoflurane in patients with a seizure disorder or who are at risk for seizures. Use of inhaled anesthetics has been associated with rare increases in serum potassium concentrations that have resulted in cardiac arrhythmias and death in pediatric patients during the postoperative period. Concomitant use of succinylcholine has been associated with most, but not all, of these cases. Patients with latent or overt neuromuscular disease, particularly Duchenne muscular dystrophy, appear to be most vulnerable. Early and aggressive intervention to treat the hyperkalemia and resistant arrhythmias is recommended as is subsequent evaluation for latent neuromuscular disease.